Cobra provides a comprehensive biologics and pharmaceuticals service offering, with multi-functional and experienced project teams nurturing customers’ DNA, Viral Vector and Microbiota products from pre-clinical through to clinical and commercial manufacture within GMP approved facilities.
Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector Combines Cognate’s Comprehensive Cell...
Find Out More
Thomas Moore, Science and Medical Correspondent Sky News, is joined by Prof. Lindy Durrant, immunologist and joint CEO/CSO of Scancell, and Alex...
Find Out More
Providing large scale manufacturing capacity for AZD1222
Find Out More
Speak to a member of our expert team and arrange to take a tour of our GMP facilities in the UK and Sweden.
